With a market cap of $92.3 billion, KKR & Co. Inc. (KKR) is a leading global investment firm providing alternative ****** et management, capital markets, and insurance solutions. With a patient and disciplined investment approach, the company seeks to generate attractive returns through strategic investments in private equity, credit, real ****** ets, and insurance solutions.
Shares of the New York-based company have lagged behind the broader market over the past 52 weeks. KKR stock has decreased 28.1% over this time frame, while the broader S&P 500 Index ($SPX) has returned 21.3%. Moreover, shares of the company are down 19.5% on a YTD basis, compared to SPX's 13.2% gain.
Don't ****** ume Micron Will Share SanDisk's Fate. Here's Why.
The Nvidia-SpaceX Deal Is Sending a Clear Signal on AI Dominance
Rocket Lab Investors Have Plenty to Cheer Ahead of Q2 Earnings Today

#company #insurance #york #index

Pfizer Inc (NYSE:PFE, XETRA:PFE) beat Wall Street expectations for its second-quarter 2026 results and raised the midpoint of its full-year revenue guidance, as growth from launched and acquired products helped offset declines in its COVID-19 portfolio.
The pharmaceutical company reported adjusted earnings of $0.77 per share for the quarter, above the $0.68 expected by ****** ysts. Revenue came in at $15.03 billion, compared with the $14.40 billion consensus estimate.
Pfizer reported quarterly revenue of $15.0 billion, up 1% on an operational basis from a year earlier. Excluding Comirnaty and Paxlovid, revenue increased 5% operationally, while revenue from launched and acquired products rose 18% operationally.
The company reported a GAAP loss of $0.04 per share, reflecting $4.3 billion in non-cash intangible ****** et impairments.
Pfizer raised its 2026 revenue guidance by $500 million at the midpoint to a range of $60.5 billion to $62.5 billion. The company reaffirmed its adjusted diluted earnings guidance of $2.80 to $3.00 per share, which includes an approximately $0.10 impact from its transaction with Innovent Biologics.

#company

Hyperscale Data Inc. (NYSE: $GPUS) has begun using part of its bitcoin treasury to fund construction at its Michigan AI data center campus, turning a balance-sheet reserve into capital for a long-term compute buildout.
The company said it has monetized about 100 bitcoin (CRYPTO: $BTC) and directed the proceeds toward construction, critical infrastructure and long-lead equipment tied to a previously announced master services agreement with an unnamed neo-cloud AI infrastructure provider.
That agreement initially covers roughly 20 megawatts of critical AI compute capacity and runs for 10 years, with two five-year extension options. Hyperscale Data expects the contract to generate more than $1.2 billion if it reaches the maximum term.
More From Cryptoprowl:
Ramp Network Brings Multichain Wallet and Rewards to EU

#hyperscale #long #compute

Cathie Wood doesn't mind volatility. The founder, CEO, and chief investment officer of Ark Invest went shopping as many of her existing positions were sinking.
Ark bought more shares of Tesla (NASDAQ: TSLA), **** e Exploration Technologies (NASDAQ: SPCX), and Meta Platforms (NASDAQ: META) last week. The stocks would go on to decline between 7% and 18% for the week. Let's take a closer look at some of Wood's most prolific trades from the past week, each one among the 10 largest companies by market cap.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
It's been a **** py road for the world's largest automaker by market cap. Tesla stock has fallen 16% in the final two trading days of last week, after the company posted disappointing financial results. The pullback isn't a fluke. Tesla has now fallen a humbling 37% since peaking seven months ago. Tesla entered this week just 5% away from taking out its 52-week low.
The second-quarter results were problematic. Total revenue rose 26% to $28.2 billion, but that was largely expected. Tesla had announced a 25% jump in vehicles delivered during the last three months three weeks ago. It's commendable that Tesla is growing its flagship business, following back-to-back quarters of sequential declines after the end of federal tax credits for electric vehicles in the third quarter of last year. The report gets worse once you get past the top-line results.

#last #NVIDIA #flashing

Our ****** ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Delivered strong first-half momentum by balancing volume growth and price/mix, achieving organic revenue growth at the high end of the long-term algorithm.
Leveraged the FIFA World Cup activation to drive record beverage incidence of over 80% at venues, utilizing integrated marketing to engage consumers across 180 markets.
Navigated an uneven global consumer environment by sharpening Revenue Growth Management (RGM) toolkits, balancing affordability for pressured consumers with premiumization for resilient segments.
Achieved broad-based volume growth across all operating units, supported by the relaunch of Mr. Pibb and continued expansion of Coca-Cola Zero Zero into evening consumption occasions.

#balancing #NVIDIA

Interested in Nokia Corporation? Here are five stocks we like better.
Nokia posted stronger Q2 2026 results, with 9% constant-currency net sales growth and improved margins. Network Infrastructure led the gain, while comparable operating profit rose to EUR 434 million and gross margin increased to 46%.
AI and cloud demand was a major growth driver, with sales from those customers more than doubling to EUR 446 million and order intake reaching EUR 2.8 billion. Management warned the orders were lumpy and that about half should convert to revenue within the next 12 months.
Nokia highlighted strategic investments in AI-RAN and optical capacity, including the launch of its first commercial AI-RAN platform and expansion of manufacturing in San Jose, Pennsylvania, and Arizona. The company also maintained its outlook, though it expects third-quarter mobile margins to dip before improving later in the year.
The New Nokia: A Bullish Upgrade Ignites This Big AI Bet

#Growth #million

Starbucks (NASDAQ: SBUX) earned about half as much in fiscal 2025 as it did the year before. Yet the stock is acting as if the opposite happened. Shares sit near $105 as of this writing, within about 4% of their 52-week high of $109.23.
That disconnect is the whole story with this stock right now. The market is paying up for CEO Brian Niccol's turnaround before it fully shows up in profits. And based on the number that leads this kind of recovery (customer traffic), there's a chance that the market has it right.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
But can the turnaround's momentum persist?
The next piece of evidence arrives Wednesday, July 29, when the coffee giant reports fiscal third-quarter results.

#fiscal

As the Iran war enters another volatile phase, Newmont (NEM) seemingly makes for a great contrarian trade. Sure, NEM stock is currently sitting on an 88% Strong Sell rating by the Barchart Technical Opinion indicator. However, it's possible that the escalation of hostilities could provide a temporary boost to the share price. Also, because NEM is down nearly 12% in the trailing month, it may be a positive mean-reversion candidate.
Another wrinkle to support the short-term bull case is Newmont's upcoming second-quarter earnings report. On July 23 after the market close, the gold miner is scheduled to release its financial results, with ***** ysts calling for earnings per share of $2.18 on revenue of $6.38 billion. Given the fact that Newmont has enjoyed generally strong results in recent quarters, another beat wouldn't be out of the question.
Intel Stock Is Down, But Put Premiums are High - Put Short Sellers Love the High Yields
Netflix Tanks on Lower Margins and Flat Outlook - Time to Buy NFLX?
Huge, Unusual Intel Options Volume Today Ahead of Earnings This Week

#newmont #strong #short

The benchmark diesel price used as the basis for most fuel surcharges rose this week by the second-largest amount since the start of the Iran war.
The Department of Energy/Energy Information Administration average retail diesel price climbed 33.8 cents/gallon to $5.134/g, published Tuesday but effective Monday.
The size of the increase is the second largest since the benchmark price rose 96.2 cts/g on March 9, the first time the DOE/EIA price measured a full week of market movement following the launch of military action against Iran by the U.S. and Israel on February 28/March 1.
With the benchmark price having moved up sharply two weeks in a row, it is now 55.6 cts/g more than where it stood just three weeks ago.
Retail prices, as they generally do, are reacting after the fact to increases in the price of ultra low sulfur diesel (ULSD) on the CME commodity exchange.

#retail #week

The S&P 500 Index ($SPX) (SPY) today is up +0.23%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.26%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.31%. September E-mini S&P futures (ESU26) are up +0.27%, and September E-mini Nasdaq futures (NQU26) are up +0.21%.
Stock indexes are moving higher today, with the S&P 500 posting a 1-month high following today's US economic news, which showed that June producer prices rose less than expected and the July Empire manufacturing survey rose more than expected.
Elon Musk Dubs Him 'Scam Altman' Not Sam — Then Altman Clapped Back: 'Homeboy You're The One Selling **** e Datacenters'
Oracle Stock Crashes to a 52-Week Low. Here's Why It Might Be Time to Buy.
Short Seller Hunterbrook Attacked Bloom Energy's Supply-Chain Claims. BE Stock Is Bruised, But Not Broken.

Access to this page has been denied because we believe you are using automation tools to browse the website.
This may happen as a result of the following:
Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
Reference ID: #218cafe1 -7ccd-11f1-9f9b-895e2792da36

We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is one of the best healthcare stocks on our list.
TheFly reported on July 2 that UBS ******* yst Ashwani Verma initiated coverage of CRNX with a Buy rating and a $55 price target. The ******* yst noted that the stock's 44% decline since mid-January presents an appealing opportunity for investors. UBS highlighted CRNX's pipeline as having multiple potential catalysts, supported by programs with strong chances of clinical success. The firm expressed the highest confidence in the Phase 3 atumelnant program for congenital adrenal hyperplasia and projects peak sales potential of approximately $2.0 billion.
In other news, on July 6, Vertex Pharmaceuticals and Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) announced a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, representing an equity value of approximately $10 billion, or about $8.8 billion after accounting for estimated acquired cash. The transaction received unanimous approval from both companies' boards and is expected to close in the third quarter of 2026. Vertex stated that CRNX's endocrine-focused portfolio, including PALSONIFY and atumelnant, aligns with its strategy of developing transformative medicines for diseases with significant unmet needs. The acquisition is expected to support Vertex's revenue growth, with the combined ******* ets projected to provide more than $5 billion in potential peak annual revenue.
Crinteics Pharmaceuticals, Inc. (NASDAQ:CRNX) is a clinical-stage biopharmaceutical company focused on developing oral, non-peptide therapies for endocrine diseases and tumors by targeting G-protein-coupled receptors (GPCRs). Its key programs include PALSONIFY (paltusotine), an FDA- and EMA-approved oral treatment for acromegaly; atremelnant, a Phase 3 therapy for congenital adrenal hyperplasia and Cushing's syndrome; and a pipeline targeting conditions such as Graves' disease, obesity, and other endocrine disorders, and this is what makes the company innovative.
While we acknowledge the potential of CRNX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

With a market cap of $282.8 billion, KLA Corporation (KLAC) is a global leader in advanced process control and process-enabling solutions for the electronics and semiconductor manufacturing industry. Working closely with customers worldwide, KLA's teams of scientists, engineers, and data experts develop innovative equipment and services that drive advancements in wafer, reticle, integrated circuit, packaging, and printed circuit board manufacturing.
The Milpitas, California-based company is slated to announce its fiscal Q4 2026 results soon. Ahead of this event, ******* ysts expect KLAC to report an adjusted EPS of $1, a 6.4% rise from $0.94 in the year-ago quarter. It has exceeded or met Wall Street's earnings expectations in the past four quarters.
Nasdaq Futures Plunge as Samsung Sparks Chip Selloff
AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to Buy and Hold for the Next 10 Years
The Nasdaq-100 Could Be Forming a Textbook Diamond Top. Here's What to Watch on the QQQ Chart Now.

The S&P/ASX Small Ordinaries index was weaker on Wednesday, falling 43.70 points, or 1.27%, to 3,390.80.
The move extended recent weakness for the small-cap benchmark, which is now down 56.10 points, or 1.63%, over the past five trading days.
Several ASX-listed resource stocks have delivered operational, corporate and strategic updates this morning, with gold production, leadership appointments, project consolidation and critical minerals strategy among the key themes.
Alkane Resources Ltd (ASX:ALK, OTC:ALKEF) produced 42,491 ounces of gold equivalent during the June quarter, covering the period from April 1 to June 30, 2026.
The company ended the quarter in a strong financial position, with cash of $432 million, bullion valued at $7 million and listed investments worth $15 million, taking total liquidity and investments to $454 million.

NVDY's distributions have collapsed from $2.62 monthly in March 2024 to roughly $0.10 per week in 2026 as NVIDIA's volatility moderated and NAV eroded.
NVIDIA surged roughly 24% over the past year and 854% over five years, but NVDY structurally cannot capture those gains because sold calls cap every rally.
NVDY suits income-focused investors who accept a slowly shrinking NAV, but a dividend growth ETF or personally selling covered calls delivers better total returns.
It sounds nuts, but SoFi is giving new active invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for yourself (Sponsor)
YieldMax NVDA Option Income Strategy ETF (NYSEARCA:NVDY) monetizes NVIDIA's (NASDAQ:NVDA) volatility through a synthetic covered-call strategy, converting option premiums into weekly cash distributions. The fund once ranked among the highest-yielding listed ETFs, but the critical question is whether those distributions represent durable income or a slow-motion return of your own capital. The answer, based on the May 2026 fact sheet and recent distribution data, is more nuanced than the headline yield suggests.

Artisan Partners, an investment management firm, issued its first-quarter 2026 investor letter for the "Artisan Mid Cap Value Fund". A copy of this letter is available for download here. In Q1 2026, the portfolio underperformed the benchmark Russell Midcap Value Index as the market favored momentum-driven stocks over quality factors. Some holdings faced company-specific setbacks and negative sentiment. The Fund's Investor Class: ARTQX returned -4.93%, Advisor Class: APDQX declined by -4.90%, and Institutional Class: APHQX fell by -4.97%, all trailing the Index's 3.68% gain. The equity market in the quarter was mixed, with mid- and small-cap indices showing resilience despite lagging large-cap growth stocks. Volatility increased, initially fueled by interest in AI and private credit, but escalated after the outbreak of war in Iran, leading to rising oil prices. Sector performance varied, with energy leading the gains. The Fund continues to seek companies capable of value growth during market dislocations at attractive entry points. Also, review the Fund's top five holdings to see its best picks for 2026.
In its first-quarter 2026 investor letter, Artisan Mid Cap Value Fund highlighted Gartner, Inc. (NYSE:IT). Established in 1979, Gartner, Inc. (NYSE:IT) is a research and advisory company that provides business and technology insights to help businesses make informed decisions. On July 7, 2026, Gartner, Inc. (NYSE:IT) closed at $140.80 per share. One-month return of Gartner, Inc. (NYSE:IT) was -9.11%, and its shares lost 64.30% over the past 52 weeks. Gartner, Inc. (NYSE:IT) has a market capitalization of $9.43 billion.
Artisan Mid Cap Value Fund stated the following regarding Gartner, Inc. (NYSE:IT) in its Q1 2026 investor letter:
"Among the biggest decliners were ICON, Humana, Gartner, Inc. (NYSE:IT) and Pinterest, each of which dropped by 30% or more during the quarter. Gartner, a technology and business advisory firm, declined following signs of slowing growth and a weaker-than-expected outlook for 2026. Its core research business has been affected by several cyclical headwinds, including US government cost-cutting, uncertainty around trade policy and longer sales cycles. At the same time, some investors have become concerned about the potential long-term impact of artificial intelligence on Gartner's business model. While we take these risks seriously, we believe the company's current challenges are primarily cyclical, and any meaningful disruption from AI is likely to play out over a longer time horizon. Gartner continues to generate strong free cash flow, maintains a solid balance sheet and has been returning capital to shareholders, including approximately $2 billion of share repurchases in 2025. At current levels, we believe the stock appears attractively valued."

Is VRSN a good stock to buy? We came across a bullish thesis on VeriSign, Inc. on StockCompass's Substack. In this article, we will summarize the bulls' thesis on VRSN. VeriSign, Inc.'s share was trading at $255.90 as of July 1st. VRSN's trailing and forward P/E were 27.80 and 26.88 respectively according to Yahoo Finance.
Rawpixel.com/Shutterstock.com
VeriSign, Inc., together with its subsidiaries, provides internet infrastructure and domain name registry services that enables internet navigation for various recognized domain names worldwide. VRSN is positioned as one of the internet's most durable and defensive businesses, operating the exclusive registry for .com and .net domain names under long-term agreements with the U.S. Department of Commerce and ICANN.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential

Apple Inc. (NASDAQ:AAPL) is one of the 15 Best AI Stocks That Will Make You Rich in 10 Years.
On June 26, 2026, Bloomberg's Mark Gurman reported that Apple Inc. (NASDAQ:AAPL) is planning a major change to its Mac chip roadmap, citing people with knowledge of the matter. Apple is expected to launch a base M6 chip for entry-level Macs as early as this year while skipping M6 Pro and Max variants. Higher-end performance upgrades are instead expected to be reserved for an AI-focused M7 generation in 2027, with more significant computing and graphics advances. Gurman wrote that the shift should help meet demand for on-device AI capabilities and more graphics-intensive software.
On June 25, Evercore ISI noted that Apple made the "rare move" of raising prices intra-cycle across select Macs, iPads, and home devices. The firm called the hikes "a surprise," saying increases of 17% to 25% across the core Mac and iPad lineup should help protect gross margins but could create demand friction. Evercore ISI maintained an Outperform rating and $365 price target on Apple shares, which were down about 5% to $277.65 in morning trading.
Earlier, Apple confirmed price hikes on several MacBook and iPad products, saying the consumer electronics industry is facing an "unprecedented challenge" as AI data center growth drives higher memory and storage demand. Apple said it had "reached a point" where it needed to raise prices on some products, while noting it is working to find solutions.
Giuseppe Costantino/Shutterstock.com

Updated June 26, 2026, 4:27 pm EDT / Original June 26, 2026, 7:44 am EDT
Stocks finished lower Friday
as tech shares extended their recent slump and chip makers broadly declined. Investors continued to rotate out of AI momentum names and into lagging sectors.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8